What is Cagrilintide?
Cagrilintide is a long-acting amylin analog that influences appetite and satiety. It has been studied both on its own and in combination with semaglutide (as CagriSema) for weight management.
Also known as: Cagri, AM833
How Cagrilintide is studied
Cagrilintide is a long-acting analog of amylin, a hormone co-released with insulin that promotes satiety and slows gastric emptying. It is studied on its own and combined with semaglutide (as CagriSema) for appetite and weight management.
Commonly researched for
Typically stacked with
Research status
Important considerations
Investigational and not approved as a standalone product. Medical supervision advised.
Cagrilintide — frequently asked questions
Appetite regulation and weight management, both alone and in combination with semaglutide. It is investigational.
Amylin is a hormone released with insulin that promotes fullness; a long-acting analog like cagrilintide extends that satiety effect.
No. It is investigational and studied in clinical trials, not approved as a standalone product.